Weili Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Weili Wang has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Jishi Wang
Department of Hematology, Affiliated Hospital of Guizhou Medical University, Guiyang, China
5 shared publications Chengyun Pan
Department of Haematology, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guiyang, China
3 shared publicationsJu-Kun Song
College of Stomatology, Guizhou Medical University, Guiyang, China
3 shared publicationsMing Ni
Department of Haematology, Affiliated Hospital of Guizhou Medical University, Guizhou Province Institute of Hematology, Guiyang, China
3 shared publications- Qin Fang
Department of Pharmacy, Affiliated Hospital of Guizhou Medical University, Guizhou, China
3 shared publications - Shensui Li
College of Stomatology, Guizhou Medical University, China; Department of Oral and Maxillofacial Surgery, the Affiliated Stomatological Hospital of Guizhou Medical University, No. 9, Beijing Road, Yunyan District, Guiyang City, Guizhou Province 550004, China
3 shared publications
Latest Publications
- 13 September 2026
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 26 (10) , 109
Revealing the Link Between Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Stroke: A Comprehensive Epidemiological and Network Toxicology Perspective
Per- and polyfluoroalkyl substances (PFAS) are persistent environmental pollutants associated with cardiovascular disease; however, their association with stroke risk remains insufficiently characterized. Critical knowledge gaps remain regarding the dose-response relationships, mixture effects, and biological pathways potentially linking PFAS to cerebrovascular disease. We initially screened 50,912 U.S. adults from NHANES (2003–2012) and included eligible participants to examine associations between serum PFAS concentrations, including PFOA, PFOS, PFHxS, and PFNA, and self-reported stroke. Weighted generalized linear models assessed exposure-response relationships and weighted quantile sum (WQS) regression were used to evaluate PFAS mixture effects. Causal mediation analysis quantified the contributions of serum lipids (total cholesterol [TC] and LDL-cholesterol) to the PFAS-stroke associations. Individual PFAS showed positive associations with stroke. Near-linear dose-response curves suggested no apparent thresholds for PFOA, PFHxS, and PFNA (all P for trend < 0.01), while PFOS exhibited a threshold effect at 3.73 ng/mL (95% CI: 3.15–4.28). WQS regression indicated that PFAS mixtures were positively associated with stroke risk (OR = 1.52; 95% CI: 1.17–1.97), with PFOS contributing the largest mixture weight (0.39). Mediation analyses indicated TC and LDL mediated 2.07–11.22% of the PFAS-stroke associations (P mediation < 0.05). This study establishes PFAS exposure, particularly PFOS-dominated mixtures, may represent an environmental correlate of stroke risk, with lipid dysregulation potentially contributing to this association. Strategies aimed at reducing PFOS exposure may help mitigate the potential cerebrovascular burden associated with PFAS exposure.
- 13 September 2026
- Published by Springer Nature in Cardiovascular Toxicology
- Vol. 26 (10) , 109
Revealing the Link Between Exposure to Per- and Polyfluoroalkyl Substances (PFAS) and Stroke: A Comprehensive Epidemiological and Network Toxicology Perspective
Per- and polyfluoroalkyl substances (PFAS) are persistent environmental pollutants associated with cardiovascular disease; however, their association with stroke risk remains insufficiently characterized. Critical knowledge gaps remain regarding the dose-response relationships, mixture effects, and biological pathways potentially linking PFAS to cerebrovascular disease. We initially screened 50,912 U.S. adults from NHANES (2003–2012) and included eligible participants to examine associations between serum PFAS concentrations, including PFOA, PFOS, PFHxS, and PFNA, and self-reported stroke. Weighted generalized linear models assessed exposure-response relationships and weighted quantile sum (WQS) regression were used to evaluate PFAS mixture effects. Causal mediation analysis quantified the contributions of serum lipids (total cholesterol [TC] and LDL-cholesterol) to the PFAS-stroke associations. Individual PFAS showed positive associations with stroke. Near-linear dose-response curves suggested no apparent thresholds for PFOA, PFHxS, and PFNA (all P for trend < 0.01), while PFOS exhibited a threshold effect at 3.73 ng/mL (95% CI: 3.15–4.28). WQS regression indicated that PFAS mixtures were positively associated with stroke risk (OR = 1.52; 95% CI: 1.17–1.97), with PFOS contributing the largest mixture weight (0.39). Mediation analyses indicated TC and LDL mediated 2.07–11.22% of the PFAS-stroke associations (P mediation < 0.05). This study establishes PFAS exposure, particularly PFOS-dominated mixtures, may represent an environmental correlate of stroke risk, with lipid dysregulation potentially contributing to this association. Strategies aimed at reducing PFOS exposure may help mitigate the potential cerebrovascular burden associated with PFAS exposure.
- 4 May 2026
- Published by Elsevier in Archives of Oral Biology
- Vol. 188, 106607
P75NTR promotes radiation-induced submandibular gland epithelial cell apoptosis via the ceramide signaling
- 4 May 2026
- Published by Elsevier in Archives of Oral Biology
- Vol. 188, 106607
P75NTR promotes radiation-induced submandibular gland epithelial cell apoptosis via the ceramide signaling
- 24 March 2026
- Published by Elsevier in Archives of Oral Biology
- Vol. 187, 106578
Hsa-miR-514a-3p suppresses oral squamous cell carcinoma(OSCC) progression by targeting COL1A1
- 24 March 2026
- Published by Elsevier in Archives of Oral Biology
- Vol. 187, 106578
Hsa-miR-514a-3p suppresses oral squamous cell carcinoma(OSCC) progression by targeting COL1A1
- Open Access
- 13 December 2025
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 17 (1)
Mesenchymal stem cell therapy for radiation-induced xerostomia: a systematic review and network meta-analysis
Radiation-induced xerostomia (RIX) is a frequent, debilitating complication of head and neck radiotherapy for cancer. Preclinical studies suggest that mese
- 13 December 2025
- Published by Springer Nature in Stem Cell Research & Therapy
- Vol. 17 (1)
Open AccessMesenchymal stem cell therapy for radiation-induced xerostomia: a systematic review and network meta-analysis
Radiation-induced xerostomia (RIX) is a frequent, debilitating complication of head and neck radiotherapy for cancer. Preclinical studies suggest that mese
- 1 June 2025
- Vol. 43 (3) , 422-430
[Clinical analysis of changes in the position of the condyle and temporomandibular joint after repair of mandibular defects].
This retrospective study aimed to investigate factors influencing positional changes of the condyle and temporomandibular joint (TMJ) following mandibular defect reconstruction with bone flaps, and to evaluate the biomechanical impacts of flap reconstruction on condylar positioning, thereby providing evidence for optimizing surgical protocols and TMJ functional rehabilitation. A retrospective study was conducted on 90 patients undergoing mandibular segmental resection with immediate bone flap reconstruction at Guizhou Medical University Affiliated Stomatological Hospital (June 2019 to May 2024). After strict screening, 50 cases with complete data were analyzed. Clinical parameters (defect size, location, reconstruction method) and craniofacial CT scans at four timepoints [preoperative (T0), 7-10 days (T1), 3 months (T2), and 6 months (T3) postoperatively] were collected. Mimics 20 software facilitated 3D reconstruction for measuring TMJ anterior/posterior/superior joint spaces (Kamelchuk method) and calculating condylar position via the Pullinger index [Ln (posterior/anterior space)]. Vitral and Krisjane methods quantified mandibular linear parameters (ramus length, condylar pole distances to the sagittal plane, angulation) and glenoid fossa morphology. Statistical analyses were performed using SPSS 21.0. Mandibular defect size and location were significant factors influencing postoperative condylar position changes (PPPPPP<0.05). Condylar position changes after mandibular defect repair with bone flap reconstruction are associated with the size and location of the defect. Additionally, adaptive remodeling of the temporomandibular joint (TMJ) joint space occurs postoperatively. The phenomenon of anterior displacement of the condyle in the early postoperative period (7-10 days) shows a trend of reduction with prolonged follow-up time, and further sample size research is needed.
- 1 June 2025
- Vol. 43 (3) , 422-430
[Clinical analysis of changes in the position of the condyle and temporomandibular joint after repair of mandibular defects].
This retrospective study aimed to investigate factors influencing positional changes of the condyle and temporomandibular joint (TMJ) following mandibular defect reconstruction with bone flaps, and to evaluate the biomechanical impacts of flap reconstruction on condylar positioning, thereby providing evidence for optimizing surgical protocols and TMJ functional rehabilitation. A retrospective study was conducted on 90 patients undergoing mandibular segmental resection with immediate bone flap reconstruction at Guizhou Medical University Affiliated Stomatological Hospital (June 2019 to May 2024). After strict screening, 50 cases with complete data were analyzed. Clinical parameters (defect size, location, reconstruction method) and craniofacial CT scans at four timepoints [preoperative (T0), 7-10 days (T1), 3 months (T2), and 6 months (T3) postoperatively] were collected. Mimics 20 software facilitated 3D reconstruction for measuring TMJ anterior/posterior/superior joint spaces (Kamelchuk method) and calculating condylar position via the Pullinger index [Ln (posterior/anterior space)]. Vitral and Krisjane methods quantified mandibular linear parameters (ramus length, condylar pole distances to the sagittal plane, angulation) and glenoid fossa morphology. Statistical analyses were performed using SPSS 21.0. Mandibular defect size and location were significant factors influencing postoperative condylar position changes (PPPPPP<0.05). Condylar position changes after mandibular defect repair with bone flap reconstruction are associated with the size and location of the defect. Additionally, adaptive remodeling of the temporomandibular joint (TMJ) joint space occurs postoperatively. The phenomenon of anterior displacement of the condyle in the early postoperative period (7-10 days) shows a trend of reduction with prolonged follow-up time, and further sample size research is needed.
- RetractionOpen Access
- 8 May 2025
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 32 (6) , 739
Retraction Note: Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
- 8 May 2025
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 32 (6) , 739
RetractionOpen AccessRetraction Note: Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
- Open Access
- 26 April 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 297, 118244
Network toxicological and molecular docking in investigating the mechanisms of toxicity of agricultural chemical pyraclostrobin
- 26 April 2025
- Published by Elsevier in Ecotoxicology and Environmental Safety
- Vol. 297, 118244
Open AccessNetwork toxicological and molecular docking in investigating the mechanisms of toxicity of agricultural chemical pyraclostrobin
- RetractedOpen Access
- 29 August 2022
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 29 (11) , 1804-1805
Correction: Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
- 29 August 2022
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 29 (11) , 1804-1805
RetractedOpen AccessCorrection: Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
- RetractedOpen Access
- 15 July 2022
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 29 (11) , 1773-1790
RETRACTED ARTICLE: Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
Drug resistance is a key factor in the treatment failure of acute myeloid leukemia (AML). Nuclear factor E2-related factor 2 (Nrf2) plays a crucial role in tumor chemotherapy resistance. However, the potential mechanism of Nrf2 regulating DNA mismatch repair (MMR) pathway to mediate gene-instability drug resistance in AML is still unclear. Here, it was found that Nrf2 expression was closely related to the disease progression of AML as well as highly expressed in AML patients with poor prognostic gene mutations. Meanwhile, it was also found that the expression of Nrf2 was significantly negatively correlated with DNA MMR gene replication factor C4 (RFC4) in AML. CHIP analysis combined with luciferase reporter gene results further showed that Nrf2 may inhibit the expression of RFC4 by its interaction with the RFC4 promoter. In vitro and vivo experiments showed that the overexpression of Nrf2 decreased the killing effect of chemotherapy drug cytarabine (Ara-C) on leukemia cells and inhibited the expression of RFC4. Mechanistically, The result that Nrf2-RFC4 axis mediated AML genetic instability drug resistance might be received by activating the JNK/NF-κB signaling pathway. Taken together, these findings may provide a new idea for improving AML drug resistance.
- 15 July 2022
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 29 (11) , 1773-1790
RetractedOpen AccessRETRACTED ARTICLE: Nrf2 overexpression increases the resistance of acute myeloid leukemia to cytarabine by inhibiting replication factor C4
Drug resistance is a key factor in the treatment failure of acute myeloid leukemia (AML). Nuclear factor E2-related factor 2 (Nrf2) plays a crucial role in tumor chemotherapy resistance. However, the potential mechanism of Nrf2 regulating DNA mismatch repair (MMR) pathway to mediate gene-instability drug resistance in AML is still unclear. Here, it was found that Nrf2 expression was closely related to the disease progression of AML as well as highly expressed in AML patients with poor prognostic gene mutations. Meanwhile, it was also found that the expression of Nrf2 was significantly negatively correlated with DNA MMR gene replication factor C4 (RFC4) in AML. CHIP analysis combined with luciferase reporter gene results further showed that Nrf2 may inhibit the expression of RFC4 by its interaction with the RFC4 promoter. In vitro and vivo experiments showed that the overexpression of Nrf2 decreased the killing effect of chemotherapy drug cytarabine (Ara-C) on leukemia cells and inhibited the expression of RFC4. Mechanistically, The result that Nrf2-RFC4 axis mediated AML genetic instability drug resistance might be received by activating the JNK/NF-κB signaling pathway. Taken together, these findings may provide a new idea for improving AML drug resistance.
- 5 July 2021
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 28 (10-11) , 1227
Correction: C3a and C5a facilitates the metastasis of myeloma cells by activating Nrf2
- 5 July 2021
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 28 (10-11) , 1227
Correction: C3a and C5a facilitates the metastasis of myeloma cells by activating Nrf2